Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, IL

Clinical Trial Details


Research Study Summary

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Efficacy and Safety Trial of Bapineuzumab (AAB-001) in Subjects with Mild to Moderate Alzheimer’s Disease who are Apolipoprotein E e4 Carriers


The purpose of this study is to test if bapineuzumab is effective and safe in treating Alzheimer’s Disease. This will be done during this study using tests that show how you are doing over time with memory, day to day activities, and other measures of brain function and disease.

Please contact Alexian Brothers for more information on participation.

To Learn more

CW ID: 176862
Date Last Changed: July 22, 2013

Clinical Trial Snapshot

Both Male and Female
Overall Status
Facility Type


Alexian Brothers Hospital Network
800 Biesterfield Road Brock Building First Floor
Elk Grove Village, IL 60007
Phone: 847-593-8553

View Map

Research Center Information:

Alexian Brothers Hospital Network

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.